These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

339 related articles for article (PubMed ID: 28768876)

  • 1. Monoclonal Antibodies against Zika Virus: Therapeutics and Their Implications for Vaccine Design.
    Wang Q; Yan J; Gao GF
    J Virol; 2017 Oct; 91(20):. PubMed ID: 28768876
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of Virus-Like-Particle Vaccine and Reporter Assay for Zika Virus.
    Garg H; Sedano M; Plata G; Punke EB; Joshi A
    J Virol; 2017 Oct; 91(20):. PubMed ID: 28794019
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Monoclonal Antibodies against Zika Virus NS1 Protein Confer Protection via Fc
    Yu L; Liu X; Ye X; Su W; Zhang X; Deng W; Luo J; Xiang M; Guo W; Zhang S; Xu W; Yan Q; Wang Q; Cui Y; Wu C; Guo W; Niu X; Zhang F; Lei C; Qu L; Chen L; Feng L
    mBio; 2021 Feb; 12(1):. PubMed ID: 33563822
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recombinant Chimpanzee Adenovirus Vaccine AdC7-M/E Protects against Zika Virus Infection and Testis Damage.
    Xu K; Song Y; Dai L; Zhang Y; Lu X; Xie Y; Zhang H; Cheng T; Wang Q; Huang Q; Bi Y; Liu WJ; Liu W; Li X; Qin C; Shi Y; Yan J; Zhou D; Gao GF
    J Virol; 2018 Mar; 92(6):. PubMed ID: 29298885
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Large-scale analysis of B-cell epitopes of envelope: Implications for Zika vaccine and immunotherapeutic development.
    Almansour I; Alfares R; Aljofi H
    F1000Res; 2018; 7():1624. PubMed ID: 31316749
    [No Abstract]   [Full Text] [Related]  

  • 6. Neutralizing human antibodies prevent Zika virus replication and fetal disease in mice.
    Sapparapu G; Fernandez E; Kose N; Bin Cao ; Fox JM; Bombardi RG; Zhao H; Nelson CA; Bryan AL; Barnes T; Davidson E; Mysorekar IU; Fremont DH; Doranz BJ; Diamond MS; Crowe JE
    Nature; 2016 Dec; 540(7633):443-447. PubMed ID: 27819683
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Potential targets for therapeutic intervention and structure based vaccine design against Zika virus.
    Qadir A; Riaz M; Saeed M; Shahzad-Ul-Hussan S
    Eur J Med Chem; 2018 Aug; 156():444-460. PubMed ID: 30015077
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Zika virus like particles elicit protective antibodies in mice.
    Salvo MA; Kingstad-Bakke B; Salas-Quinchucua C; Camacho E; Osorio JE
    PLoS Negl Trop Dis; 2018 Feb; 12(2):e0006210. PubMed ID: 29401460
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Zika Virus Envelope Protein and Antibody Complexes.
    Dai L; Wang Q; Song H; Gao GF
    Subcell Biochem; 2018; 88():147-168. PubMed ID: 29900496
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunization with phage virus-like particles displaying Zika virus potential B-cell epitopes neutralizes Zika virus infection of monkey kidney cells.
    Basu R; Zhai L; Contreras A; Tumban E
    Vaccine; 2018 Feb; 36(10):1256-1264. PubMed ID: 29395533
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Vaccine Based on a Modified Vaccinia Virus Ankara Vector Expressing Zika Virus Structural Proteins Controls Zika Virus Replication in Mice.
    Pérez P; Q Marín M; Lázaro-Frías A; Jiménez de Oya N; Blázquez AB; Escribano-Romero E; S Sorzano CÓ; Ortego J; Saiz JC; Esteban M; Martín-Acebes MA; García-Arriaza J
    Sci Rep; 2018 Nov; 8(1):17385. PubMed ID: 30478418
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immune Responses to Dengue and Zika Viruses-Guidance for T Cell Vaccine Development.
    Roth C; Delgado FG; Simon-Lorière E; Sakuntabhai A
    Int J Environ Res Public Health; 2018 Feb; 15(2):. PubMed ID: 29473899
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chimeric yellow fever 17D-Zika virus (ChimeriVax-Zika) as a live-attenuated Zika virus vaccine.
    Giel-Moloney M; Goncalvez AP; Catalan J; Lecouturier V; Girerd-Chambaz Y; Diaz F; Maldonado-Arocho F; Gomila RC; Bernard MC; Oomen R; Delagrave S; Burdin N; Kleanthous H; Jackson N; Heinrichs J; Pugachev KV
    Sci Rep; 2018 Sep; 8(1):13206. PubMed ID: 30181550
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Human Bi-specific Antibody against Zika Virus with High Therapeutic Potential.
    Wang J; Bardelli M; Espinosa DA; Pedotti M; Ng TS; Bianchi S; Simonelli L; Lim EXY; Foglierini M; Zatta F; Jaconi S; Beltramello M; Cameroni E; Fibriansah G; Shi J; Barca T; Pagani I; Rubio A; Broccoli V; Vicenzi E; Graham V; Pullan S; Dowall S; Hewson R; Jurt S; Zerbe O; Stettler K; Lanzavecchia A; Sallusto F; Cavalli A; Harris E; Lok SM; Varani L; Corti D
    Cell; 2017 Sep; 171(1):229-241.e15. PubMed ID: 28938115
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ribosome display for the rapid generation of high-affinity Zika-neutralizing single-chain antibodies.
    Kunamneni A; Ye C; Bradfute SB; Durvasula R
    PLoS One; 2018; 13(11):e0205743. PubMed ID: 30444865
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunization of Zika virus envelope protein domain III induces specific and neutralizing immune responses against Zika virus.
    Yang M; Dent M; Lai H; Sun H; Chen Q
    Vaccine; 2017 Jul; 35(33):4287-4294. PubMed ID: 28669618
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A DNA Vaccine Protects Human Immune Cells against Zika Virus Infection in Humanized Mice.
    Yi G; Xu X; Abraham S; Petersen S; Guo H; Ortega N; Shankar P; Manjunath N
    EBioMedicine; 2017 Nov; 25():87-94. PubMed ID: 29033368
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rational Engineering and Characterization of an mAb that Neutralizes Zika Virus by Targeting a Mutationally Constrained Quaternary Epitope.
    Tharakaraman K; Watanabe S; Chan KR; Huan J; Subramanian V; Chionh YH; Raguram A; Quinlan D; McBee M; Ong EZ; Gan ES; Tan HC; Tyagi A; Bhushan S; Lescar J; Vasudevan SG; Ooi EE; Sasisekharan R
    Cell Host Microbe; 2018 May; 23(5):618-627.e6. PubMed ID: 29746833
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Maternal immunization with a DNA vaccine candidate elicits specific passive protection against post-natal Zika virus infection in immunocompetent BALB/c mice.
    Wang R; Liao X; Fan D; Wang L; Song J; Feng K; Li M; Wang P; Chen H; An J
    Vaccine; 2018 Jun; 36(24):3522-3532. PubMed ID: 29753607
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular determinants of human neutralizing antibodies isolated from a patient infected with Zika virus.
    Wang Q; Yang H; Liu X; Dai L; Ma T; Qi J; Wong G; Peng R; Liu S; Li J; Li S; Song J; Liu J; He J; Yuan H; Xiong Y; Liao Y; Li J; Yang J; Tong Z; Griffin BD; Bi Y; Liang M; Xu X; Qin C; Cheng G; Zhang X; Wang P; Qiu X; Kobinger G; Shi Y; Yan J; Gao GF
    Sci Transl Med; 2016 Dec; 8(369):369ra179. PubMed ID: 27974667
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.